Cargando…
Prospects of HA-Based Universal Influenza Vaccine
Current influenza vaccines afford substantial protection in humans by inducing strain-specific neutralizing antibodies (Abs). Most of these Abs target highly variable immunodominant epitopes in the globular domain of the viral hemagglutinin (HA). Therefore, current vaccines may not be able to induce...
Autor principal: | Hashem, Anwar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345066/ https://www.ncbi.nlm.nih.gov/pubmed/25785268 http://dx.doi.org/10.1155/2015/414637 |
Ejemplares similares
-
Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults
por: Fadlyana, Eddy, et al.
Publicado: (2023) -
Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020) -
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
por: Myers, Mallory L., et al.
Publicado: (2023) -
Prospects for Universal Influenza Virus Vaccine
por: Gerhard, Walter, et al.
Publicado: (2006) -
372. Co-Administration of OVX836, NP-Based Universal Influenza Vaccine Candidate, with Conventional HA-Based Influenza Vaccine: Results of Phase 2a Clinical trial
por: Willems, Paul, et al.
Publicado: (2023)